Response to comment on "Comment on characteristics of metabolic inflammatory syndrome among inpatients with type 2 diabetes: A cross-sectional study in China".

Xue, Mengjuan; Lu, Bin · Prim Care Diabetes · 2025

Where this comes from

Abstract

This manuscript addresses several comments raised by Dr. Liao on metabolic inflammatory syndrome (MIS) in type 2 diabetes inpatients. It explains the limitations including selection bias in the study population, lack of exploration of molecular mechanisms, and discrepancies in dyslipidemia findings.

Medical subject headings